Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Active Ankylosing Spondylitis (ATLAS)
NCT00085644Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jan 2004
- Primary completion
- Dec 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in ankylosing spondylitis (AS), sponsored by Abbott Laboratories. Started Jan 2004; status: completed.
02
Drugs
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00085644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085644.